| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.32▼ | 4.38▼ | 4.35▼ | 3.97▲ | 3.81▲ |
| MA10 | 4.37▼ | 4.31▼ | 4.22▲ | 3.55▲ | 3.07▲ |
| MA20 | 4.39▼ | 4.24▲ | 4.25▲ | 3.56▲ | 2.75▲ |
| MA50 | 4.32▼ | 4.09▲ | 3.77▲ | 2.81▲ | 2.30▲ |
| MA100 | 4.23▲ | 3.71▲ | 3.58▲ | 2.65▲ | 2.46▲ |
| MA200 | 4.23▲ | 3.60▲ | 3.29▲ | 2.29▲ | 2.45▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.025▼ | 0.002▲ | -0.016▼ | 0.053▲ | 0.194▲ |
| RSI | 36.085▼ | 51.382▲ | 56.871▲ | 68.082▲ | 71.115▲ |
| STOCH | 53.048 | 75.962 | 60.640 | 69.897 | 87.181▲ |
| WILL %R | -69.565 | -44.444 | -51.181 | -19.443▲ | -12.782▲ |
| CCI | -157.530▼ | 20.258 | 4.941 | 141.101▲ | 150.533▲ |
| ▲ GAP | $IMMX Open Gap Up %2 | Set Alert |
|
Wednesday, November 12, 2025 05:51 AM
- Rare disease commercial veteran Mr. Grabow to lead Immix’s U.S. launch and commercial buildout for NXC-201 in relapsed/refractory AL Amyloidosis, a serious, rare, blood disease with no currently ...
|
|
Thursday, November 06, 2025 10:39 AM
Immix Biopharma, Inc. is building strength in its pipeline with impressive early signals in AL amyloidosis. Learn more about IMMX stock here.
|
|
Monday, November 03, 2025 12:45 AM
Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), the global leader in relapsed/refractory AL Amyloidosis, today announced that Phase 1/2 interim results from its U.S. NXC-201 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 18/11/25 | 4.125 | 4.50 | 4.02 | 4.26 | 577,658 |
| 17/11/25 | 4.20 | 4.60 | 3.94 | 4.04 | 1,501,921 |
| 14/11/25 | 3.57 | 4.29 | 3.5584 | 4.21 | 1,183,399 |
| 13/11/25 | 3.73 | 3.75 | 3.45 | 3.61 | 781,087 |
| 12/11/25 | 3.26 | 3.8499 | 3.26 | 3.72 | 1,294,840 |
| 11/11/25 | 3.22 | 3.454 | 3.16 | 3.23 | 311,389 |
| 10/11/25 | 3.26 | 3.53 | 3.18 | 3.24 | 375,567 |
| 07/11/25 | 3.01 | 3.22 | 2.8901 | 3.15 | 457,450 |
| 06/11/25 | 3.06 | 3.12 | 2.8513 | 3.03 | 601,453 |
| 05/11/25 | 3.31 | 3.46 | 3.00 | 3.05 | 627,754 |
|
|
||||
|
|
||||
|
|